ARCHIVES

BioSeek Awarded NIH SBIR For Compound Validation.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

SEER Expects To Lower Cancer Incidence Rates for Blacks by 3%

September 27, 2002

$25 Million In Federal Aid to Jackson Laboratory approved By Senate; NIH, Natcher Are Opposed

August 11, 1989

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

Boyd’s Rebuttal to DePinho’s Letter to the AAUP

May 30, 2014

RFA: Long-Term Cancer Survivors

September 12, 1997

Judge Rules First Amendment Protects Distribution Of Off-Label Use Information

August 14, 1998